Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics and Optimal Dosage of Caspofungin in Critically Ill Patients With Suspected Invasive Candidiasis

NCT01994096 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT01994096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01994096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics and Optimal Dosage of Caspofungin in Critically Ill Patients With Suspected Invasive Candidiasis
Lead sponsor
University Medical Center Groningen
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2013
Completion date
October 31, 2015
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critically ill, suspected invasive candidiasis